90 Days Gen AI Risk Trial -Start Now
Book a demo
Healthcare Automation·Unknown; likely clinical/enterprise licensing·neuproscan.com

Neuproscan

Neuproscan is an AI platform for predicting dementia onset from MRI scans, aiding early diagnosis of Alzheimer's by detecting subtle indicators.

Risk Score
Medium
4/10

Independent assessment across data handling, compliance, security and transparency.

Risk factors

3
  • Cloud-based service with potential data exposure
  • User-uploaded medical data may be processed
  • No clear opt-out for training on user-generated content

Recommendations

2
  • Ensure compliance with healthcare data regulations
  • Consider self-hosted alternatives for sensitive content

Data handling

Storage
Cloud-based; MRI/medical imaging data uploaded
Retention
Unknown; PHI retention requires strict controls
Training on inputs
Unknown; PHI must not be used for training without explicit consent